A number of factors, such as histological grade, type and size of tumor, lymph node metastasis, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu), influence the prognosis and response to the treatment of cancer [4]. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.